Lv3
318 积分 2024-04-06 加入
Exploring the role of ITGB6: fibrosis, cancer, and other diseases
10天前
已完结
PK/PD Evaluation of Antibody–Drug Conjugates with Enhanced Immune Effector Functions
17天前
已完结
Epidermal Growth Factor Receptor Expression and Gene Copy Number in Conventional Hepatocellular Carcinoma
25天前
已完结
Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer
1个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
2个月前
已完结
Mechanistic insights into Wnt–β-catenin pathway activation and signal transduction
2个月前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
2个月前
已完结
Stereotactic Body Radiation Therapy With Continued First-Line PD-1 Inhibitor-based Therapy as a Resistance-Overcoming Strategy in Oligoprogressive Hepatocellular Carcinoma: A Prospective Phase 2 Clinical Study
2个月前
已关闭
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naive Advanced Hepatocellular Carcinoma: Long-Term Follow-Up of Open-Label, Phase 2 KEYNOTE-224 Study
2个月前
已完结
Pan-cancer single-cell landscape of tumor-infiltrating T cells
2个月前
已完结
皖公网安备34019202002308
